Beyond market trends, investors keen on maximizing returns delve into the world of stock picking. The right selections can be instrumental in catapulting your wealth.
As of close of business last night, Chromadex Corp’s stock clocked out at $7.90, up 0.25% from its previous closing price of $7.88. In other words, the price has increased by $0.25 from its previous closing price. On the day, 1.35 million shares were traded.
Ratios:
To gain a deeper understanding of CDXC’s stock, we examine its different ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 13.75 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 51.66. For the most recent quarter (mrq), Quick Ratio is recorded 3.06 and its Current Ratio is at 3.57. In the meantime, Its Debt-to-Equity ratio is 0.06 whereas as Long-Term Debt/Eq ratio is at 0.04.
On August 11, 2022, B. Riley Securities Downgraded its rating to Neutral which previously was Buy and also lowered its target price recommendation from $6 to $2.40.
On March 08, 2022, ROTH Capital started tracking the stock assigning a Buy rating and target price of $7.ROTH Capital initiated its Buy rating on March 08, 2022, with a $7 target price.
Insider Transactions:
Investing in insider trades can also provide an investor with insight into how management views future stock prices. A recent insider transaction in this stock occurred on Mar 07 ’25 when Lopez Carlos Luis bought 273 shares for $7.86 per share. The transaction valued at 2,146 led to the insider holds 2,251 shares of the business.
Jaksch Frank L Jr sold 37,161 shares of CDXC for $229,956 on Dec 13 ’24. The Director now owns 244,179 shares after completing the transaction at $6.19 per share. On Dec 13 ’24, another insider, Frank Jaksch Jr., who serves as the affiliate of the company, bought 37,161 shares for $6.19 each.
Valuation Measures:
As of this moment, Chromadex’s Price-to-Earnings (P/E) ratio for their current fiscal year is 75.02, and their Forward P/E ratio for the next fiscal year is 38.54. The expected Price-to-Earnings-to-Growth (PEG) calculation for the next 5 years is 2.61. For the stock, the TTM Price-to-Sale (P/S) ratio is 6.17 while its Price-to-Book (P/B) ratio in mrq is 13.25.
Stock Price History:
Over the past 52 weeks, CDXC has reached a high of $9.18, while it has fallen to a 52-week low of $1.72. The 50-Day Moving Average of the stock is 34.94%, while the 200-Day Moving Average is calculated to be 76.02%.
Shares Statistics:
A total of 77.33M shares are outstanding, with a floating share count of 49.23M. Insiders hold about 36.68% of the company’s shares, while institutions hold 29.21% stake in the company.
